These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 24281376)

  • 1. Treatment of hyperammonemia in liver failure.
    Jover-Cobos M; Khetan V; Jalan R
    Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):105-10. PubMed ID: 24281376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Overt Hepatic Encephalopathy.
    Sussman NL
    Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia-lowering strategies for the treatment of hepatic encephalopathy.
    Rose CF
    Clin Pharmacol Ther; 2012 Sep; 92(3):321-31. PubMed ID: 22871998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refining the ammonia hypothesis: a physiology-driven approach to the treatment of hepatic encephalopathy.
    Tapper EB; Jiang ZG; Patwardhan VR
    Mayo Clin Proc; 2015 May; 90(5):646-58. PubMed ID: 25865476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Ammonia-Lowering Agents for Hepatic Encephalopathy.
    Rahimi RS; Rockey DC
    Clin Liver Dis; 2015 Aug; 19(3):539-49. PubMed ID: 26195207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New strategies for treating hepatic encephalopathy.
    Gómez-Gutiérrez C; Manzano-Robleda MC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2014; 13(3):409-11. PubMed ID: 24756021
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prevention and treatment of hepatic encephalopathy].
    Sivolap YP
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(10):144-147. PubMed ID: 29171503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy for the treatment and prevention of hepatic encephalopathy.
    Mohammad RA; Regal RE; Alaniz C
    Ann Pharmacother; 2012 Nov; 46(11):1559-63. PubMed ID: 23092866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced removal of nitrogen derivatives in urine: a new concept whose time has come.
    Córdoba J; Ventura-Cots M
    Hepatology; 2014 Mar; 59(3):764-6. PubMed ID: 24123173
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized, double-blind, controlled study of glycerol phenylbutyrate in hepatic encephalopathy.
    Rockey DC; Vierling JM; Mantry P; Ghabril M; Brown RS; Alexeeva O; Zupanets IA; Grinevich V; Baranovsky A; Dudar L; Fadieienko G; Kharchenko N; Klaryts'ka I; Morozov V; Grewal P; McCashland T; Reddy KG; Reddy KR; Syplyviy V; Bass NM; Dickinson K; Norris C; Coakley D; Mokhtarani M; Scharschmidt BF;
    Hepatology; 2014 Mar; 59(3):1073-83. PubMed ID: 23847109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy for hyperammonemia.
    Hadjihambi A; Khetan V; Jalan R
    Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment options for hepatic encephalopathy.
    Schiano TD
    Pharmacotherapy; 2010 May; 30(5 Pt 2):16S-21S. PubMed ID: 20412036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic encephalopathy: pathophysiology and emerging therapies.
    Sundaram V; Shaikh OS
    Med Clin North Am; 2009 Jul; 93(4):819-36, vii. PubMed ID: 19577116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal treatment of hepatic encephalopathy.
    Waghray A; Waghray N; Kanna S; Mullen K
    Minerva Gastroenterol Dietol; 2014 Mar; 60(1):55-70. PubMed ID: 24632768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clearance and production of ammonia quantified in humans by constant ammonia infusion - the effects of cirrhosis and ammonia-targeting treatments.
    Eriksen PL; Djernes L; Vilstrup H; Ott P
    J Hepatol; 2023 Aug; 79(2):340-348. PubMed ID: 37061198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ammonia and amino acid profiles in liver cirrhosis: effects of variables leading to hepatic encephalopathy.
    Holecek M
    Nutrition; 2015 Jan; 31(1):14-20. PubMed ID: 25220875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interorgan ammonia metabolism in liver failure: the basis of current and future therapies.
    Wright G; Noiret L; Olde Damink SW; Jalan R
    Liver Int; 2011 Feb; 31(2):163-75. PubMed ID: 20673233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dispelling myths in the treatment of hepatic encephalopathy.
    Shawcross D; Jalan R
    Lancet; 2005 Jan 29-Feb 4; 365(9457):431-3. PubMed ID: 15680459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of rifaximin and lactulose for the treatment of hepatic encephalopathy: a prospective randomized study.
    Paik YH; Lee KS; Han KH; Song KH; Kim MH; Moon BS; Ahn SH; Lee SJ; Park HJ; Lee DK; Chon CY; Lee SI; Moon YM
    Yonsei Med J; 2005 Jun; 46(3):399-407. PubMed ID: 15988813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study.
    Weiss N; Tripon S; Lodey M; Guiller E; Junot H; Monneret D; Mayaux J; Brisson H; Mallet M; Rudler M; Imbert-Bismut F; Thabut D;
    Fundam Clin Pharmacol; 2018 Apr; 32(2):209-215. PubMed ID: 29239015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.